NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/24/2023
Back to search
Official data from USPTO
MEDS2BEDS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
10/24/2023
Trademark type
Combined
Nice classes
35, 39
Filing date
04/05/2021
Registration date
10/24/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/24/2023
Last transaction
10/24/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/17/2023
First use in commerce
03/17/2023
Drawing code
3
Owner type
03
Owner location
Joliet, IL
Examiner
STANWOOD, STEPHEN
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a teal cross with the term "MEDS2BEDS" to the right of the cross. The terms "MEDS" and "BEDS" are in navy color. The "2" is in teal color. The vertical bar of the cross consists of the shape of medical pill with a horizontal line down the middle.
Holders and representatives
Holders
St. Jude Pharmacy, Inc.
Representatives
Heather L. Blaise BLAISE & NITSCHKE, PC
Technical classification
Nice Classes
Class 35Class 39
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Pharmaceutical servicesprocessing telephone prescription orders in retail and central fill pharmacies in the hospital setting
Class 39
Distribution servicesdelivery of medications
Publications
History of USPTO decisions and trademark events.
37 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/24/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/22/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/21/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/21/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/05/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/05/2023
GNRT
NON-FINAL ACTION E-MAILED
04/05/2023
CNRT
SU - NON-FINAL ACTION - WRITTEN
04/05/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/05/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/05/2023
IUAF
USE AMENDMENT FILED
03/20/2023
EISU
TEAS STATEMENT OF USE RECEIVED
03/20/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/25/2023
EX1G
SOU EXTENSION 1 GRANTED
02/23/2023
EXT1
SOU EXTENSION 1 FILED
02/23/2023
EEXT
SOU TEAS EXTENSION RECEIVED
02/23/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/23/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/28/2022
PUBO
PUBLISHED FOR OPPOSITION
06/28/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/08/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/25/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/24/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/23/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/23/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/18/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/18/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/18/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/18/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/23/2021
GNRT
NON-FINAL ACTION E-MAILED
11/23/2021
CNRT
NON-FINAL ACTION WRITTEN
11/23/2021
DOCK
ASSIGNED TO EXAMINER
11/18/2021
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/14/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/13/2021
NWAP
NEW APPLICATION ENTERED
04/08/2021
Continuous trademark protection
Get notified about every new filing that threatens MEDS2BEDS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.